M&A

Takeda pares down products and jobs, revives Genzyme building plans
Bizjournals
Fri, 10/18/19 - 09:50 am
Takeda
Shire
M&A
layoffs
Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms
Xconomy
Wed, 10/16/19 - 12:48 pm
Alexion Pharmaceuticals
Achillion
M&A
PNH
danicopan
Soliris
With biosimilar threat under control (for now), Roche savors demand for its new drugs
Endpoints
Wed, 10/16/19 - 12:24 pm
Roche
M&A
Spark Therapeutics
China
Another hit for AbbVie: Unexpected $673M Irish tax bill adds to Allergan merger woes
Fierce Pharma
Wed, 10/16/19 - 12:18 pm
Allergan
AbbVie
Ireland
taxes
M&A
Debt-laden Takeda to sell OTC drugs in Middle East and Africa for $200m
Pharmaforum
Tue, 10/15/19 - 09:49 am
Takeda
Shire
M&A
Acino
Middle East
Africa
BridgeBio scraps plan to buy Eidos after bids rebuffed
Fierce Biotech
Mon, 10/14/19 - 09:46 am
BridgeBio
Edios Therapeutics
M&A
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Motley Fool
Fri, 10/11/19 - 10:48 pm
biotech
IPOs
M&A
AbbVie Stays Busy While Working to Complete Allergan Acquisition
BioSpace
Fri, 10/11/19 - 10:34 pm
AbbVie
Allergan
M&A
Skyrizi
Reata Pharmaceuticals
UCB strikes $2.5B deal to buy Ra for rival to Alexion's Soliris
Fierce Biotech
Thu, 10/10/19 - 12:56 pm
UCB Pharma
Ra Pharmaceuticals
M&A
zilucoplan
Alexion
Soliris
Takeda breaks into top 20 largest pharmas with Shire merger
Pharmaforum
Wed, 10/9/19 - 10:41 am
Takeda
Shire
M&A
Pharma, Biotech VC Investments Continue Shift to Early Stage Deals
Xconomy
Wed, 10/9/19 - 09:41 am
venture capital
M&A
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
Tue, 10/8/19 - 10:53 am
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
M&A Will Continue to Be a Mainstay for Growth in the Pharma Industry
BioSpace
Thu, 10/3/19 - 10:52 am
M&A
Veeva acquires Crossix, pairing doctor, patient data and marketing services
Fierce Pharma
Wed, 10/2/19 - 07:41 pm
Veeva
Crossix Solutions
Veeva Crossix
patient data
physicians
M&A
Immunovant set to land on Nasdaq via HSAC merger
Fierce Biotech
Wed, 10/2/19 - 10:56 am
Immunovant
NASDAQ
M&A
Health Sciences Acquisitions Corporation
Servier acquires lymphoma drug Pixuvri from CTI BioPharma
Pharmaceutical Business Review
Tue, 10/1/19 - 10:50 pm
Pixuvri
Servier
CTI BioPharma
M&A
lymphoma
Dova Pharma's bet on Eisai castoff spells gold as Sobi spends millions to acquire it
Endpoints
Mon, 09/30/19 - 12:06 pm
Dova Pharmaceuticals
Eisai
Swedish Orphan Biovitrum
M&A
Roche sets new deadline for Spark acquisition as divestiture speculation brews
Endpoints
Mon, 09/30/19 - 12:00 pm
Roche
Spark Therapeutics
M&A
FTC requests AbbVie, Allergan for more information on $63 billion deal
Reuters
Sat, 09/28/19 - 04:31 pm
FTC
M&A
AbbVie
Allergan
As Celgene becomes BMS, its I&I lead lands CEO job at Takeda spinoff
Fierce Biotech
Fri, 09/27/19 - 10:08 am
Celgene
Bristol-Myers Squibb
M&A
Terrie Curran
Phathom

Pages